DCAT

Exploring CMO Strategies with Chris Preti (DCAT Week)
June 23, 2023

Chris Preti, CEO of Jubilant HollisterStier Contract Manufacturing Services, shares insight into the outsourcing industry.

Investigating the Pharmaceutical Ingredients Industry with Myrna Wilson (DCAT Week 2023)
May 26, 2023

Myrna Wilson, director, Global Marketing, Strategic Growth and Technical Sales, Pharmaceutical Ingredients, Univar Solutions, discusses the state of the biopharma supply chain, movements in the patent industry, and more.

Unpacking the Pharma Packaging Market with Andrea Lodetti (DCAT Week 2023)
May 25, 2023

Andrea Lodetti, CEO of Bormioli Pharma, an Italian pharma primary packaging manufacturer, speaks about his company's approach to the US market, supply chain instabilities, sustainability, and more.

Investigating Inhalation Forms and Drug Delivery with Shabbir Mostafa (DCAT Week)
May 19, 2023

Shabbir Mostafa, head of Business Development — Advanced Delivery Systems, Recipharm, sat down with Grant Playter, associate editor, during DCAT week to discuss the current state of inhalations forms and drug delivery.

Exploring Drug Storage, Drug Dosage, and the Supply Chain with Ulrike Lemke (DCAT Week)
May 12, 2023

Dr. Ulrike Lemke, Head of Sterile Fill Finish at Recipharm, sat down with Grant Playter, associate editor, to discuss drug delivery forms.

Exploring Bile Acid Therapeutics with Roger Viney (DCAT Week)
May 01, 2023

Roger Viney, chief commercial officer at ICE Pharma, discusses the history and current use of bile acid therapeutics.

Exploring the Future of Outsourcing with Sarah Stevens (DCAT Week)
April 28, 2023

Sarah Stevens, senior vice-president and head of Drug Product Development & Manufacturing at Quotient Sciences, discusses various facets of the modern outsourcing industry.

Discussing Oligonucleotides, Sustainability, and Yams with Rafael Antunes (DCAT Week)
April 22, 2023

Rafael Antunes, vice-president of Business Development Europe at Aurisco, speaks about his company's recent efforts in the field of oligonucleotides, its partnership with Cytiva, and its broader sustainability efforts.

Diving Deep into Oral Biologics with Gregor Kawaletz (DCAT 2023)
April 20, 2023

Gregor Kawaletz, head of Oral Solid Dose Business Unit at Recipharm, discusses the immediate future of oral biologics

Setting Sustainability Goals with Pierre Luzeau (DCAT 2023)
March 30, 2023

Pierre Luzeau, CEO of Seqens, discusses Seqen's commitment to sustainability and how one can work toward it within their own company.